ClinConnect ClinConnect Logo
Search / Trial NCT05530408

Quantitative Pulmonary Imaging Registry & Biorepository

Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Sep 2, 2022

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Xenon Xe 129 Ct

ClinConnect Summary

This clinical trial, called the Quantitative Pulmonary Imaging Registry & Biorepository, is focused on improving how we use advanced imaging techniques, like MRI and CT scans, to better understand and treat lung diseases. Researchers are collecting images and biological samples from people who are already involved in related studies at the University of Kansas Medical Center. By doing this, they hope to discover how these imaging methods can help doctors diagnose and manage pulmonary conditions more effectively in the future.

To participate, you need to be between 65 and 74 years old and currently enrolled in a research study that includes Pulmonary MRI or CT scans. If you choose to join, you'll be contributing to important research that could lead to new ways of using imaging to help patients with lung diseases. It's important to know that the only way to be excluded from the study is if you decide not to participate. This is a great opportunity to be part of a project that aims to advance lung health research!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The participant is enrolling/has enrolled in a research study at the University of Kansas Medical Center that involves Pulmonary MRI and/or Pulmonary CT.
  • Exclusion Criteria:
  • The participant declines to participate.

About University Of Kansas Medical Center

The University of Kansas Medical Center (KUMC) is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent clinical trial sponsor, KUMC leverages its extensive expertise in diverse medical fields to conduct rigorous clinical research aimed at improving patient outcomes and developing new treatment modalities. With a commitment to ethical standards and patient safety, KUMC collaborates with multidisciplinary teams to facilitate groundbreaking studies that address significant health challenges, ultimately contributing to the advancement of medical knowledge and the enhancement of community health.

Locations

Kansas City, Kansas, United States

Patients applied

0 patients applied

Trial Officials

Peter J Niedbalski, PhD

Principal Investigator

Research Assistant Professor

Luigi R Boccardi, MPH

Study Director

Director of Pulmonary, Critical Care, & Sleep Research

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials